Description

Book Synopsis
Drug synthesis comprises the heart of the pharmaceutical business today. Both in early development (identifying and optimizing a lead) as well as in process development (scale-up), the ability to develop elegant and economical synthetic routes proves tantamount to the commercial success of a drug.

Trade Review
“…the authors have made an excellent selection of drugs and the coverage of the synthetic chemistry employed in their production is exemplary…” (Chemistry & Industry, 5th September 2005)

"…a clear and easy to use reference for anyone working in drug discovery and development." (E-STREAMS, January 2005)

"...a very useful book...for...pharmaceutical industry scientists...[and] the larger medicinal and organic chemistry community..." (Journal of Medicinal Chemistry, November 18, 2004)

"…an outstanding primer on methods for chemical drug synthesis…the test is most useful, well written, and serves as a useful read for those interested in drug synthesis." (American Journal of Therapeutics, September/October 2004)

“…highly interesting…keeps to the facts…” (www.organische-chemie.ch)

‘…I warmly recommend this book to synthetic organic chemists both in industry and in academia.' (Organic Process Research and Development Journal, July 2007)



Table of Contents
Preface v

Trade Names and Their Corresponding USANs xi

Acronyms and Abbreviations xiii

Chapter 1. Antithrombotics: Ticlopidine (Ticlid) and Clopidogrel (Plavix) 1

Chapter 2. Anti-inflammatory Cyclooxygenase-2 Selective Inhibitors: Celecoxib (Celebrex) and Rofecoxib (Vioxx) 11

Chapter 3. H+/K+ -ATPase Inhibitors: Esomeprazole (Nexium) 21

Chapter 4. Protein-tyrosine Kinase Inhibitors: Imatnib (Gleevec) and Gefitinib (Iressa) 29

Chapter 5. Non-sedating Antihistamines 39

Chapter 6. Cosmeceuticals: Istretinoin (Accutane), Tazarotene (Tazorac), Minoxidil (Rogaine), and Finasteride (Propecia) 55

Chapter 7. Antibacterials: Ciprofloxacin (Cipro) and Linezolid (Zyvox) 75

Chapter 8. Atypical Antupsychotics 89

Chapter 9. Atovastatin Calcium (Lipitor) 113

Chapter 10. Antidepressants 125

Chapter 11. Anti-obesity: Orlistat (Xenical) 149

Chapter 12. Triptans for Migrane 161

Chapter 13. PDE 5 Inhibitors for Erectile Dysfunction: Sildenafil (Viagra), Vardenafil (Levitra), and Tadalafil (Cialis) 189

Chapter 14. Antiasthmatics 201

Index 214

Contemporary Drug Synthesis

    Product form

    £121.46

    Includes FREE delivery

    RRP £134.95 – you save £13.49 (9%)

    Order before 4pm tomorrow for delivery by Tue 23 Jun 2026.

    A Hardback by Bruce D. Roth, Douglas S. Johnson, Drago R. Sliskovic


      View other formats and editions of Contemporary Drug Synthesis by Bruce D. Roth

      Publisher: Wiley
      Publication Date: 13/07/2004
      ISBN13: 9780471214809, 978-0471214809
      ISBN10:

      Description

      Book Synopsis
      Drug synthesis comprises the heart of the pharmaceutical business today. Both in early development (identifying and optimizing a lead) as well as in process development (scale-up), the ability to develop elegant and economical synthetic routes proves tantamount to the commercial success of a drug.

      Trade Review
      “…the authors have made an excellent selection of drugs and the coverage of the synthetic chemistry employed in their production is exemplary…” (Chemistry & Industry, 5th September 2005)

      "…a clear and easy to use reference for anyone working in drug discovery and development." (E-STREAMS, January 2005)

      "...a very useful book...for...pharmaceutical industry scientists...[and] the larger medicinal and organic chemistry community..." (Journal of Medicinal Chemistry, November 18, 2004)

      "…an outstanding primer on methods for chemical drug synthesis…the test is most useful, well written, and serves as a useful read for those interested in drug synthesis." (American Journal of Therapeutics, September/October 2004)

      “…highly interesting…keeps to the facts…” (www.organische-chemie.ch)

      ‘…I warmly recommend this book to synthetic organic chemists both in industry and in academia.' (Organic Process Research and Development Journal, July 2007)



      Table of Contents
      Preface v

      Trade Names and Their Corresponding USANs xi

      Acronyms and Abbreviations xiii

      Chapter 1. Antithrombotics: Ticlopidine (Ticlid) and Clopidogrel (Plavix) 1

      Chapter 2. Anti-inflammatory Cyclooxygenase-2 Selective Inhibitors: Celecoxib (Celebrex) and Rofecoxib (Vioxx) 11

      Chapter 3. H+/K+ -ATPase Inhibitors: Esomeprazole (Nexium) 21

      Chapter 4. Protein-tyrosine Kinase Inhibitors: Imatnib (Gleevec) and Gefitinib (Iressa) 29

      Chapter 5. Non-sedating Antihistamines 39

      Chapter 6. Cosmeceuticals: Istretinoin (Accutane), Tazarotene (Tazorac), Minoxidil (Rogaine), and Finasteride (Propecia) 55

      Chapter 7. Antibacterials: Ciprofloxacin (Cipro) and Linezolid (Zyvox) 75

      Chapter 8. Atypical Antupsychotics 89

      Chapter 9. Atovastatin Calcium (Lipitor) 113

      Chapter 10. Antidepressants 125

      Chapter 11. Anti-obesity: Orlistat (Xenical) 149

      Chapter 12. Triptans for Migrane 161

      Chapter 13. PDE 5 Inhibitors for Erectile Dysfunction: Sildenafil (Viagra), Vardenafil (Levitra), and Tadalafil (Cialis) 189

      Chapter 14. Antiasthmatics 201

      Index 214

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account